We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2897:TSENissin Foods Holdings Co., Ltd. Analysis

Data as of 2026-06-17 - not real-time

¥2,666.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nissin Foods is trading below its 200‑day moving average while the 20‑day SMA sits beneath the 50‑day SMA, indicating a short‑term bearish bias. The RSI hovers around the mid‑range, suggesting neither overbought nor oversold conditions. A bullish MACD histogram coupled with an increasing volume trend points to potential upside momentum building. Fundamentally, the company delivers modest revenue growth and a solid profit margin, with a forward P/E well below the current trailing P/E, implying earnings expansion ahead. The DCF‑derived fair value sits comfortably above the market price, translating to a notable upside potential. Additionally, a dividend yield above 2½ % and a payout ratio under 50 % support a sustainable income stream.
On the longer horizon, Nissin’s diversified geographic footprint across Japan, the United States and China cushions it against localized shocks, while its entrenched brand portfolio underpins stable cash generation. The combination of undervaluation, growth catalysts, and reliable dividend makes the stock an attractive candidate for medium‑ to long‑term investors, despite the near‑term bearish technical backdrop.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near 20‑day SMA and support level
  • bearish trend direction despite bullish MACD histogram
  • increasing volume but limited upside in the near term

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value above market price indicating upside
  • forward earnings expansion reflected in lower forward P/E
  • sustainable dividend yield supporting total return

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • strong global brand and product diversification
  • steady cash generation and manageable debt profile
  • blend of growth prospects and value appeal

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin5.76%
P/E Ratio17.1
ROE9.20%
ROA3.37%
Debt/Equity31.36
P/B Ratio1.5
Op. Cash Flow¥80.4B
Free Cash Flow¥-20817625088

Technical Analysis

TrendBearish
RSI46.7
Support¥2,527.00
Resistance¥2,763.50
MA 20¥2,648.20
MA 50¥2,789.92
MA 200¥2,890.15
MACDBullish
VolumeIncreasing
Fear & Greed Index92.29

Valuation

Fair Value¥2,767.33
Target Price¥3,277.27
Upside/Downside22.93%
GradeUndervalued
TypeBlend
Dividend Yield2.57%

Risk Assessment

Beta-0.01
Volatility26.91%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.